All Stories

  1. Recent Advances in the Development of Alpha-Glucosidase and Alpha-Amylase Inhibitors in Type 2 Diabetes Management: Insights from In silico to In vitro Studies
  2. In Silico Validation Studies of Cyanobacterial Bioactive Compounds Against Α-amylase and Α-glucosidase Markers in Type 2 Diabetes Mellitus
  3. Design, Sar, and Metabolism Study of Crucifereae Family Compound (Spirobrassinin) and its Analogs for Antiangiogenic Potential Targeting Hsp90
  4. Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions
  5. A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease
  6. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7
  7. Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
  8. Molecular interaction and computational analytical studies of Pinocembrin for its antiangiogenic potential targeting VEGFR-2: A persuader of metastasis
  9. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study
  10. Elucidation of Antiangiogenic Potential of Vitexin Obtained from Cucumis sativus Targeting Hsp90 Protein: A Novel Multipathway Targeted Approach to Restrain Angiogenic Phenomena
  11. Advances and Implications in Nanotechnology for Lung Cancer Management